Elmind Capital, LP
Source: SEC Form 13F · as of Mar 2026Elmind Capital, LP holds 20 biotech & pharma companies tracked by BioSniper, totaling $211.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$211.8M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Cogent Biosciences, Inc. (COGT)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| COGTCogent Biosciences, Inc. | 1,170,740 | $45.1M |
| CLDXCelldex Therapeutics, Inc. | 865,000 | $27.4M |
| CTMXCytomX Therapeutics, Inc. | 4,550,000 | $21.4M |
| KALVKalVista Pharmaceuticals, Inc. | 1,021,300 | $20.6M |
| PCVXVaxcyte, Inc. | 316,500 | $18.4M |
| PHVSPharvaris N.V. | 475,750 | $13.4M |
| BEAMBeam Therapeutics Inc. | 476,338 | $11.4M |
| VRDNViridian Therapeutics, Inc.\DE | 534,931 | $10.5M |
| CGEMCullinan Therapeutics, Inc. | 530,000 | $7.5M |
| NRIXNurix Therapeutics, Inc. | 460,000 | $7.1M |
| RLAYRelay Therapeutics, Inc. | 536,946 | $5.3M |
| TVTXTravere Therapeutics, Inc. | 177,600 | $5.3M |
| PTGXProtagonist Therapeutics, Inc | 38,000 | $4.0M |
| ALMSALUMIS INC. | 130,000 | $2.9M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 47,000 | $2.7M |
| DSGNDesign Therapeutics, Inc. | 207,900 | $2.2M |
| APLSApellis Pharmaceuticals, Inc. | 50,000 | $2.0M |
| ALECAlector, Inc. | 900,000 | $1.9M |
| IMCRImmunocore Holdings plc | 58,248 | $1.8M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 20,000 | $1.0M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.